Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Juni 2026 15:33 ET | Quelle: Cosmos Health Inc.

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
12. Juni 2026 09:29 ET | Quelle: Cosmos Health Inc.

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Cosmos Health announces strong sales momentum for its proprietary antiseptic brands, C-Scrub and C-Sept.
11. Juni 2026 15:31 ET | Quelle: Cosmos Health Inc.

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Cosmos Health signs LOI to acquire Doc Pharma S.A.
11. Juni 2026 09:35 ET | Quelle: Cosmos Health Inc.

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.
10. Juni 2026 15:32 ET | Quelle: Cosmos Health Inc.

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Cosmos Health secures a 3-year contract manufacturing agreement for 3.9 million units of VASCLOR GEST progesterone pessaries.
10. Juni 2026 09:00 ET | Quelle: Cosmos Health Inc.

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Cosmos Health CEO issues letter to shareholders.
09. Juni 2026 15:30 ET | Quelle: Cosmos Health Inc.

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Cosmos Health inaugurates state-of-the-art capsule production line and secures new 5-year contract manufacturing agreement for 385,000 units
08. Juni 2026 10:00 ET | Quelle: Cosmos Health Inc.

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Cosmos Health acquires international patent application WO2025108566A1 and expands nanotechnology initiatives.
05. Juni 2026 09:25 ET | Quelle: Cosmos Health Inc.

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Cosmos Health launches Oliv18™, a USDA and EU certified whole olive polyphenol supplement targeting cardiovascular and antioxidant categories.
04. Juni 2026 15:57 ET | Quelle: Cosmos Health Inc.

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Sky Premium Life is now available for shipment across all 27 European Union Member States through Skroutz.